SAN DIEGO, May 18, 2021 /PRNewswire/ -- BioTheryX, Inc., a clinical-stage company focused on degrading proteins to create life-saving medicines, today announced the expansion of its Scientific ...
For decades it has been an open question in the ubiquitin research field how proteins are labeled as being defective or unneeded. In their recent study Brenda Schulman, Director at the Max Planck ...
Brenda Schulman, head of the department „Molecular Machines and Signaling“ at the Max Planck Institute of Biochemistry in Martinsried receives the Gottfried Wilhelm Leibniz Prize 2019. It comes with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results